-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Atea Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2022 to Q1 2024.
- Atea Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $56.8M.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $40.3K.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$455M.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$4K, a 84.6% increase from 2020.